Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07494084 · ClinicalTrials.gov registry record · Phase 4
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
A Phase 4 study, sponsored by Washington State University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT07494084 is a Phase 4 study that has not yet begun recruiting, run by Washington State University. The registered enrollment target is 48 participants.
The verdict
NCT07494084, a Phase 4 study, has not yet begun recruiting, sponsored by Washington State University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of timed cortisol release or differently timed cortisol rhythms on insulin resistance in both men and women undergoing sleep restriction. Chronic sleep loss is highly prevalent, affecting 1 in 3 adults in the US. Chronic sleep loss causes stress which induces insulin resistance and leads to obesity and type 2 diabetes. Many factors contribute to sleep loss including shift work, environmental disturbances, sleep/circadian disorders and comorbid medical and mental health conditions. Sleep loss increases the stress hormone cortisol in the evening and decreases daytime testosterone. Examining these hormones in a controlled laboratory environment under different sleep schedules may help researchers find solutions for adults experiencing negative health consequences related to chronic sleep loss.
Interventions
- DRUG Dextrose
- DRUG insulin
- DRUG Metyrapone And Hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2029-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07494084
The ClinicalTrials.gov registry entry for NCT07494084 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dextrose is the first listed.
NCT07494084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07494084 about?
NCT07494084 is a clinical study titled "Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance". The purpose of this study is to examine the impact of timed cortisol release or differently timed cortisol rhythms on insulin resistance in both men and women undergoing sleep restriction. Chronic sleep loss is highly prevalent, affecting 1 in 3 adults in the US. Chronic sleep loss causes stress whi...
What is the current status of trial NCT07494084?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2026-07-01. Estimated completion is 2029-07.
What interventions are being tested in trial NCT07494084?
The interventions under investigation include: Dextrose (DRUG), insulin (DRUG), Metyrapone And Hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT07494084?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.